Aman Xu
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Gastric Cancer Management and Outcomes 10
-
- Circular RNAs in diseases 4
- Cancer-related gene regulation 2
- Co-authors
- Lei Huang (19 shared papers)Ruolin Wu (1 shared paper)Zhijian Wei (15 shared papers)Yuanhong Xu (3 shared papers)Xinyue Zhang (1 shared paper)Jingjing Xu (2 shared papers)Xiuwen Zhang (2 shared papers)Lingli Zhang (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Oncotarget (3 papers)Journal of Cancer (2 papers)Microvascular Research (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaGermanySaudi Arabia
In The Last Decade
Aman Xu
35 papers receiving 989 citations
Aman Xu's Hit Papers
Peers
Comparison fields: 5 of 97
- Modeling and Simulation 74
- Cancer Research 191
- Pulmonary and Respiratory Medicine 239
- Oncology 160
- Infectious Diseases 102
Countries citing papers authored by Aman Xu
This map shows the geographic impact of Aman Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aman Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aman Xu more than expected).
Fields of papers citing papers by Aman Xu
This network shows the impact of papers produced by Aman Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aman Xu. The network helps show where Aman Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Aman Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study Hit paper breakdown → | 2020 | 237 |
| 2 | Epithelial-mesenchymal transition in gastric cancer. | 2015 | 220 |
| 3 | 2014 | 70 | |
| 4 | SET and MYND domain containing protein 3 in cancer. | 2017 | 40 |
| 5 | 2019 | 39 | |
| 6 | 2019 | 36 | |
| 7 | 2018 | 33 | |
| 8 | 2015 | 31 | |
| 9 | 2022 | 31 | |
| 10 | 2018 | 25 | |
| 11 | 2015 | 22 | |
| 12 | CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances. | 2015 | 20 |
| 13 | 2019 | 19 | |
| 14 | 2017 | 18 | |
| 15 | 2021 | 16 | |
| 16 | 2021 | 16 | |
| 17 | 2017 | 15 | |
| 18 | 2017 | 13 | |
| 19 | 2018 | 13 | |
| 20 | FTL: a novel predictor in gastric cancer. | 2017 | 12 |
About Aman Xu
Aman Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Oncology, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Cancer-related gene regulation (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Modeling and Simulation (74 citations), Cancer Research (191 citations), Pulmonary and Respiratory Medicine (239 citations), Oncology (160 citations) and Infectious Diseases (102 citations). Aman Xu has collaborated with scholars based in China, Germany and Saudi Arabia. Frequent co-authors include Lei Huang, Ruolin Wu, Zhijian Wei, Yuanhong Xu, Xinyue Zhang, Jingjing Xu, Xiuwen Zhang, Lingli Zhang, Chengyuan Zhang and Peipei Liang. Their work appears in journals such as Frontiers in Oncology, Oncotarget, Journal of Cancer, Microvascular Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.